Analyst Recommendations

Wells Fargo analyst issues OVERWEIGHT recommendation for CRWD on March 4, 2024 07:56AM ET. The previous analyst recommendation was Overweight.CRWD was trading at $314.6 at issue of the...

March 4, 2024   CRWD 3.41%

BTIG analyst issues BUY recommendation for MGNX on March 4, 2024 07:56AM ET. The previous analyst recommendation was Buy.MGNX was trading at $19.06 at issue of the analyst...

March 4, 2024   MGNX -3.33%

Wedbush analyst issues BUY recommendation for EPAM on March 4, 2024 07:00AM ET. The previous analyst recommendation was Buy.EPAM was trading at $306.83 at issue of the analyst...

March 4, 2024   EPAM 1.27%

Susquehanna analyst issues UNDERPERFORM recommendation for EPAM on March 4, 2024 07:00AM ET. The previous analyst recommendation was Underperform.EPAM was trading at $306.83 at issue of the analyst...

March 4, 2024   EPAM 1.27%

Jefferies analyst issues BUY recommendation for VEEV on March 4, 2024 07:56AM ET. The previous analyst recommendation was Buy.VEEV was trading at $222.01 at issue of the analyst...

March 4, 2024   VEEV 0.44%

Cowen & Co. analyst issues NEUTRAL recommendation for QURE on March 4, 2024 07:56AM ET. The previous analyst recommendation was Neutral.QURE was trading at $5.59 at issue of...

March 4, 2024   QURE 1.66%

Wells Fargo analyst issues OVERWEIGHT recommendation for DLTR on March 4, 2024 07:56AM ET. The previous analyst recommendation was Overweight.DLTR was trading at $148.44 at issue of the...

March 4, 2024   DLTR -1.45%

Cowen & Co. analyst issues OUTPERFORM recommendation for MTZ on March 4, 2024 07:56AM ET. The previous analyst recommendation was Outperform.MTZ was trading at $84.85 at issue of...

March 4, 2024   MTZ 0.25%

Wedbush analyst issues BUY recommendation for EPAM on March 4, 2024 07:00AM ET. The previous analyst recommendation was Buy.EPAM was trading at $306.83 at issue of the analyst...

March 4, 2024   EPAM 1.27%

Susquehanna analyst issues UNDERPERFORM recommendation for EPAM on March 4, 2024 07:00AM ET. The previous analyst recommendation was Underperform.EPAM was trading at $306.83 at issue of the analyst...

March 4, 2024   EPAM 1.27%